Literature DB >> 32935558

Pelvic Anatomical Features After Retzius-Sparing Robot-Assisted Radical Prostatectomy Intended for Early Recovery of Urinary Symptoms.

Yuya Ota1, Shuzo Hamamoto1, Nayuka Matsuyama1, Takashi Hamakawa2, Shoichiro Iwatsuki1, Toshiki Etani1, Kazumi Taguchi1, Taku Naiki1, Ryosuke Ando1, Akihiro Nakane1, Atsushi Okada1, Noriyasu Kawai1, Yasue Kubota1,3, Takahiro Yasui1.   

Abstract

Purpose: To elucidate factors contributing to early urinary continence recovery after retzius-sparing robot-assisted radical prostatectomy (RS-RARP) by evaluating postoperative pelvic anatomical features between RS-RARP and conventional RARP (CON-RARP). Materials and
Methods: We retrospectively examined 50 men who underwent RS-RARP (n = 25; the RS-RARP group) and CON-RARP (n = 25; the CON-RARP group) between October 2017 and June 2018. Perioperative outcomes and postoperative urinary continence were assessed in both groups. Anatomical features including the bladder neck-to-pubic symphysis ratio (determined from cystograms) and membranous urethral length (MUL) (determined from magnetic resonance imaging) were evaluated. Result: The daily urinary incontinence rate at discharge was significantly lower in the RS-RARP group than in the CON-RARP group (0.046 [range: 0.014-0.160] vs 0.357 [range: 0.139-0.616], p < 0.001). Postoperative urinary continence at 1, 3, 6, and 12 months was 80%, 92%, 96%, and 96% in the RS-RARP group and 24%, 40%, 68%, and 84% in the CON-RARP group, respectively (p < 0.001). The urgency scores in the international prostate symptom score (IPSS) questionnaire at 1 and 3 months were significantly lower in the RS-RARP than in the CON-RARP group (p = 0.028 and 0.033, respectively). The quality of life (QOL) indices were more significantly improved in the RS-RARP group than in the CON-RARP group 1 month (p = 0.027) and 3 months (p = 0.045) postoperatively. Receiver operating characteristic analysis revealed that a postoperative MUL of 12.1 mm (area under the curve: 0.852) was the optimal cutoff value predictive of continence recovery after 1 month. Multivariate analysis demonstrated that RS-RARP (odds ratio [OR]: 23.6; p < 0.001) and prostate volume (OR: 0.926; p = 0.049) were the independent factors of a longer MUL. Conclusions: RS-RARP results in an early continence recovery and a better urgency score in the IPSS by suppressing the descent of the bladder and maintaining a long MUL. RS-RARP may contribute to a better QOL recovery after RARP.

Entities:  

Keywords:  early urinary continence recovery; magnetic resonance imaging; membranous urethral length; radical prostatectomy; retzius-sparing; robot-assisted

Mesh:

Year:  2020        PMID: 32935558     DOI: 10.1089/end.2020.0463

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  4 in total

Review 1.  Comparison of Retzius-sparing and conventional robot-assisted laparoscopic radical prostatectomy regarding continence and sexual function: an updated meta-analysis.

Authors:  Junyan Liu; Jindong Zhang; Zongke Yang; Qingyuan Liu; Weiyang Zhang; Zizhen Qing; Delin Wang
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-10-25       Impact factor: 5.554

2.  Outcomes of Retzius-sparing versus conventional robot-assisted radical prostatectomy: A KSER update series systematic review and meta-analysis.

Authors:  Doo Yong Chung; Hae Do Jung; Do Kyung Kim; Min Ho Lee; Sin Woo Lee; Sunghyun Paick; Joo Yong Lee; Seung Hyun Jeon
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

3.  The impact of transition from conventional robot-assisted radical prostatectomy to retzius sparing robot-assisted radical prostatectomy: A retrospective multivariate analysis.

Authors:  T A Kishore; Milka James Kuriakose; Vishnu Raveendran; M K Ramaprasad
Journal:  Indian J Urol       Date:  2021-04-01

4.  Investigating the mechanism underlying urinary continence using dynamic MRI after Retzius-sparing robot-assisted radical prostatectomy.

Authors:  Yoshifumi Kadono; Takahiro Nohara; Shohei Kawaguchi; Suguru Kadomoto; Hiroaki Iwamoto; Masashi Iijima; Kazuyoshi Shigehara; Kouji Izumi; Kotaro Yoshida; Toshifumi Gabata; Atsushi Mizokami
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.